Jun Shi

P. Hu, A. Rostami-Hodjegan, Jun Shi, 2016, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

Evaluating a physiologically based pharmacokinetic model for prediction of omeprazole clearance and assessing ethnic sensitivity in CYP2C19 metabolic pathway

P. Hu, N. Parrott, O. Yin, 2015, European Journal of Clinical Pharmacology.

Discovery of an Oxycyclohexyl Acid Lysophosphatidic Acid Receptor 1 (LPA1) Antagonist BMS-986278 for the Treatment of Pulmonary Fibrotic Diseases.

C. Chu, S. Jusuf, Yanou Yang, 2021, Journal of medicinal chemistry.

Synergistic Effect and Mechanism of Cineole and Terpineol on In-vitro Transdermal Delivery of Huperzine A from Microemulsions

Qing-fei Liu, Jun Shi, G. Luo, 2013, Iranian journal of pharmaceutical research : IJPR.

Population pharmacokinetics of mycophenolic acid and its main glucuronide metabolite: a comparison between healthy Chinese and Caucasian subjects receiving mycophenolate mofetil

Jun Shi, Z. Jiao, Jing Ling, 2014, European Journal of Clinical Pharmacology.

Ligustrazine Phosphate Ethosomes for Treatment of Alzheimer’s Disease, In Vitro and in Animal Model Studies

G. Luo, Jun Shi, Yi-ming Wang, 2012, AAPS PharmSciTech.

Challenges of drug development during the COVID‐19 pandemic: Key considerations for clinical trial designs

R. Knapp, Donghao Geng, Jun Shi, 2020, British journal of clinical pharmacology.

Microemulsion-based patch for transdermal delivery of huperzine A and ligustrazine phosphate in treatment of Alzheimer’s disease

G. Luo, Qing-fei Liu, Jun Shi, 2012, Drug development and industrial pharmacy.

Ex Vivo and In Situ Evaluation of ‘Dispelling‐Wind’ Chinese Medicine Herb–Drugs on Intestinal Absorption of Chlorogenic Acid

M. Heinrich, Jun Shi, Weitong Xu, 2015, Phytotherapy research : PTR.

Single‐Dose Pharmacokinetics of Sotalol in a Pediatric Population with Supraventricular and/or Ventricular Tachyarrhythmia

J. Saul, A. Karara, M. Schaffer, 2001, Journal of clinical pharmacology.

Evaluating a physiologically based pharmacokinetic model for predicting the pharmacokinetics of midazolam in Chinese after oral administration

Pei Hu, Jun Shi, Ji Jiang, 2015, Acta Pharmacologica Sinica.

Evaluating a physiologically based pharmacokinetic model for prediction of omeprazole clearance and assessing ethnic sensitivity in CYP2C19 metabolic pathway

P. Hu, N. Parrott, O. Yin, 2015, European Journal of Clinical Pharmacology.

Globalization of Quantitative Pharmacology: First International Symposium of Quantitative Pharmacology in Drug Development and Regulation

J. Barrett, Jun Shi, M. Fossler, 2008, Journal of clinical pharmacology.

Challenges of drug development during the COVID-19 pandemic: key considerations for clinical trial designs

R. Knapp, Donghao Geng, Jun Shi, 2020 .

Pharmacodynamic Analysis of the Microbiological Efficacy of Telithromycin in Patients with Community-Acquired Pneumonia

J. Barrett, R. Port, S. Jenkins, 2005, Clinical pharmacokinetics.

Cytochrome P450 2D6 genotype affects the pharmacokinetics of controlled-release paroxetine in healthy Chinese subjects: comparison of traditional phenotype and activity score systems

P. Hu, Jun Shi, Kai Shen, 2015, European Journal of Clinical Pharmacology.

Population Pharmacokinetics and Pharmacodynamics of Sotalol in Pediatric Patients with Supraventricular or Ventricular Tachyarrhythmia

M. Gastonguay, T. Ludden, P. Hinderling, 2001, Journal of Pharmacokinetics and Pharmacodynamics.

Pharmacokinetics of Sematilide in Renal Failure

D. Sica, T. Gehr, P. Hinderling, 1996, Journal of clinical pharmacology.

Pharmacokinetic, pharmacodynamic, and safety evaluation of an accelerated dose titration regimen of sotalol in healthy middle‐aged subjects

R. Woosley, P. Hinderling, J. Barbey, 1999, Clinical pharmacology and therapeutics.

Coadministration of huperzine A and ligustrazine phosphate effectively reverses scopolamine-induced amnesia in rats

G. Luo, Jun Shi, Yi-ming Wang, 2010, Pharmacology Biochemistry and Behavior.